An additional link between endocrine disruptors and pituitary tumorigenesis was provided by the discovery of mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene in patients with pituitary tumors [21], as the aryl hydrocarbon receptor (AhR) is well-known to bind toxins and phytochemicals [22]. Here, AIP is linked to pituitary tumor.